Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger W Chapman

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Gut|July 26, 2017
A novel prognostic model for transplant-free survival in primary sclerosing cholangitisElisabeth M de Vries, Junfeng Wang, Kate D Williamson, et al.
The American Journal of Gastroenterology|April 20, 2016
Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK CohortEmma L Culver, Ross Sadler, Dawn Simpson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2020
Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitisEmma L Culver, Helen K Bungay, Margaret Betts, et al.
Scandinavian Journal of Gastroenterology|May 5, 2012
Fine mapping and replication of genetic risk loci in primary sclerosing cholangitisBrijesh Srivastava, George F Mells, Heather J Cordell, et al.
Human Molecular Genetics|August 14, 2003
Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosisAlison T Merryweather-Clarke, Estelle Cadet, Adrian Bomford, et al.
Hepatology Communications|May 16, 2018
NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acidKathy L de Graaf, Geneviève Lapeyre, Florence Guilhot, et al.
Hepatology (Baltimore, Md.)|March 26, 2016
Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignanciesMarieke E Doorenspleet, Lowiek M Hubers, Emma L Culver, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 20, 2024
Determining the time to cholangiocarcinoma in pediatric-onset PSC-IBDBatul Kaj-Carbaidwala, Johan Fevery, Douglas G Adler, et al.
Clinical Medicine (London, England)|May 17, 2020
Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related diseaseGeorge Goodchild, Rory Jr Peters, Tamsin N Cargill, et al.
Hepatology (Baltimore, Md.)|December 31, 2013
Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitisKirsten Boonstra, Emma L Culver, Lucas Maillette de Buy Wenniger, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Gut|July 26, 2017
A novel prognostic model for transplant-free survival in primary sclerosing cholangitisElisabeth M de Vries, Junfeng Wang, Kate D Williamson, et al.
The American Journal of Gastroenterology|April 20, 2016
Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK CohortEmma L Culver, Ross Sadler, Dawn Simpson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2020
Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitisEmma L Culver, Helen K Bungay, Margaret Betts, et al.
Scandinavian Journal of Gastroenterology|May 5, 2012
Fine mapping and replication of genetic risk loci in primary sclerosing cholangitisBrijesh Srivastava, George F Mells, Heather J Cordell, et al.
Human Molecular Genetics|August 14, 2003
Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosisAlison T Merryweather-Clarke, Estelle Cadet, Adrian Bomford, et al.
Hepatology Communications|May 16, 2018
NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acidKathy L de Graaf, Geneviève Lapeyre, Florence Guilhot, et al.
Hepatology (Baltimore, Md.)|March 26, 2016
Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignanciesMarieke E Doorenspleet, Lowiek M Hubers, Emma L Culver, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 20, 2024
Determining the time to cholangiocarcinoma in pediatric-onset PSC-IBDBatul Kaj-Carbaidwala, Johan Fevery, Douglas G Adler, et al.
Clinical Medicine (London, England)|May 17, 2020
Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related diseaseGeorge Goodchild, Rory Jr Peters, Tamsin N Cargill, et al.
Hepatology (Baltimore, Md.)|December 31, 2013
Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitisKirsten Boonstra, Emma L Culver, Lucas Maillette de Buy Wenniger, et al.
Pageof 7